Infectious Complications in Burn Patients: A 10-Year Multicenter Study in the Petróleos Mexicanos (PEMEX) Hospital Network
Sandra Quintana Ponce, Erika Barlandas Quintana, Nicolas Rogelio Eric Barlandas Rendon, Mercedes Calixto Galvez, Abraham Hernán Herrera-Sánchez, Mauricio Gutierrez-Alvarez, Cuahutemoc Marquez-Espriella

TL;DR
This study examines infection patterns and risk factors in burn patients across a Mexican hospital network over ten years, highlighting the role of Pseudomonas aeruginosa and antibiotic resistance.
Contribution
The study provides a decade-long multicenter analysis of burn-related infections in Latin America, identifying key risk factors and resistance trends.
Findings
Pseudomonas aeruginosa was the most frequent pathogen, with high resistance to tobramycin and imipenem.
Burns >20% TBSA, ICU stay, lower extremity involvement, and advanced age were significant infection risk factors.
The infection rate was 13.45% among 273 hospitalized burn patients.
Abstract
Background: Infectious complications are a leading cause of morbidity and mortality in burn patients, particularly in tertiary care centers treating complex cases. The loss of the skin barrier, systemic inflammatory response, and secondary immunosuppression increase susceptibility to colonization, sepsis, and multidrug-resistant infections. Understanding the epidemiology and timing of these complications is critical to optimize prevention and treatment strategies. However, multicenter data describing long-term infection patterns and antimicrobial resistance in burn patients from Latin American healthcare networks remain limited. Additionally, evaluating a decade-long cohort allows for a more comprehensive characterization of epidemiological trends and resistance profiles over time. Objective: This study aims to determine the prevalence of infectious complications, microbiological…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
| Variable | Descriptor | Value |
| Total patients | Number | 273 |
| Sex (men) | Number (%) | 196 (71.27%) |
| Sex (women) | Number (%) | 79 (28.73%) |
| Mean age (years) | Mean ± SD | 43.6 ± 18.8 |
| Median hospital stay (days) | Median | 14.5 |
| Burn region (trunk) | Number (%) | 144 (52.36%) |
| Burn region (upper extremities) | Number (%) | 90 (32.73%) |
| Burn region (head and neck) | Number (%) | 38 (13.82%) |
| Burn region (lower extremities) | Number (%) | 30 (10.91%) |
| Burn depth (first degree) | Number (%) | 7 (2.55%) |
| Burn depth (second degree) | Number (%) | 189 (68.73%) |
| Burn depth (third degree) | Number (%) | 77 (28%) |
| Burns >20% TBSA | Number (%) | 60 (21.82%) |
| Infection rate | Number (%) | 37 (13.45%) |
| Hospital | Frequency | Percentage |
| Hospital Central Norte, Mexico City | 16 | 5.82% |
| Hospital Central Sur, Mexico City | 115 | 41.82% |
| Tabasco | 39 | 14.18% |
| Poza Rica | 29 | 10.55% |
| Guanajuato | 21 | 7.64% |
| Tamaulipas | 13 | 4.73% |
| Minatitlán | 36 | 13.09% |
| Pathogen | Frequency | Percentage (%) |
| Pseudomonas aeruginosa | 21 | 7.64 |
| Staphylococcus haemolyticus | 5 | 1.82 |
| Staphylococcus epidermidis | 5 | 1.82 |
| Enterococcus faecalis | 4 | 1.45 |
| Staphylococcus hominis | 2 | 0.73 |
| Antibiotic | Resistance frequency | Resistance (%) |
| Tobramycin | 16 | 84.21 |
| Ciprofloxacin | 22 | 59.46 |
| Vancomycin | 13 | 35.14 |
| Clindamycin | 7 | 81.58 |
| Imipenem | 9 | 78.40 |
| Variable | Not infected (number (%)) | Infected (number (%)) | Chi-square | p-value | Odds ratio | 95% CI |
| Total patients | 229 (83.88%) | 44 (16.12%) | - | - | - | - |
| >60 years old | 30 (13.10%) | 17 (38.63%) | 16.88 | <0.001 | 4.18 | 2.04-8.56 |
| Diabetes mellitus | 65 (28.38%) | 8 (18.18%) | 1.96 | 0.160 | 0.56 | 0.24-1.27 |
| Arterial hypertension | 61 (26.63%) | 10 (22.72%) | 0.293 | 0.588 | 0.81 | 0.34-1.73 |
| Burns >20% TBSA | 45 (19.65%) | 15 (34.09%) | 4.48 | 0.034 | 2.11 | 1.04-4.27 |
| Burn in the head and neck | 14 (6.11%) | 4 (9.09%) | 1.02 | 0.312 | 0.57 | 0.19-1.70 |
| Burn in the trunk | 120 (52.40%) | 24 (54.54%) | 0.068 | 0.790 | 1.09 | 0.57-2.08 |
| Burn in the upper extremities | 74 (32.31%) | 16 (36.36%) | 0.274 | 0.601 | 1.19 | 0.61-2.34 |
| Burn in the lower extremities | 18 (7.86%) | 12 (27.27%) | 14.22 | 0.000 | 4.39 | 1.93-9.97 |
| ICU admission | 11 (4.80%) | 12 (27.27%) | 24.15 | 0.000 | 7.43 | 3.02-18.24 |
| Burn depth (first degree) | 7 (3.05%) | 0 (0%) | - | - | - | - |
| Burn depth (second degree) | 162 (70.74%) | 27 (61.36%) | - | - | - | - |
| Burn depth (third degree) | 60 (26.20%) | 17 (38.63%) | 3.83 | 0.147 | 1.53 | 0.11-1.23 |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBurn Injury Management and Outcomes · Wound Healing and Treatments · Nonmelanoma Skin Cancer Studies
Introduction
Burn injuries are among the most severe forms of trauma, associated with high morbidity and mortality worldwide [1]. Infection remains the leading cause of death in hospitalized burn patients [2,3]. Thermal injury compromises the skin’s barrier function and induces systemic immune dysfunction, creating a protein-rich environment conducive to microbial colonization and sepsis [4-6]. Inhalation injury is a common concomitant finding, resulting in airway edema, increased mucus production, ulceration, and obstruction of small airways by fibrinous debris, further impairing immune defense and increasing the risk of pneumonia [7].
The risk of infection is influenced by burn extent, depth, intensive care unit (ICU) admission, mechanical ventilation, and prolonged hospitalization [3,8]. Multidrug-resistant organisms (MDROs) further complicate management, emphasizing the importance of local epidemiological data to guide preventive and therapeutic strategies [9-11].
This study aimed to determine the prevalence of infectious complications, describe the microbiological profile, and identify independent risk factors among hospitalized adult burn patients treated across the Petróleos Mexicanos (PEMEX) hospital network in a multicenter cohort.
Materials and methods
We conducted a multicenter retrospective cohort study using systematically reviewed medical records of burn patients hospitalized between 2014 and 2024 across six Petróleos Mexicanos (PEMEX) hospitals in Mexico.
Study design and setting
We conducted a multicenter retrospective cohort study using systematically reviewed medical records of burn patients hospitalized between 2014 and 2024 across six Petróleos Mexicanos (PEMEX) hospitals in Mexico. Patients were followed throughout hospitalization to identify the occurrence of infectious complications.
Study population
We included adult patients (>18 years) admitted for burn treatment during the study period. Patients with incomplete records or follow-up shorter than six months were excluded.
Data collection
Demographic and clinical variables collected included age, sex, burn mechanism (flame, electrical, scald, chemical, and friction), total body surface area (TBSA) burned (<20% or ≥20%), inhalation injury, intensive care unit (ICU) admission, mechanical ventilation, hospital stay, work disability days, and mortality.
Infectious complications were recorded, including infection site, pathogen isolated, antimicrobial susceptibility patterns, sepsis, and need for debridement. Infectious complications were identified based on documented clinical diagnoses supported by microbiological confirmation when available, following institutional protocols aligned with internationally accepted burn care practices. Clinical specimens were collected according to standard care practices at each institution and processed using established microbiological methods.
Statistical analysis
Patients were categorized according to the presence or absence of infectious complications. Categorical variables were compared using the chi-square test or Fisher’s exact test, as appropriate, while continuous variables were analyzed using Student’s t-test or Mann-Whitney U test based on data distribution. Continuous variables were assessed for normality using the Shapiro-Wilk test and are presented as mean ± standard deviation (SD) or median with interquartile range, as appropriate.
Cases with incomplete key variables were excluded from regression analyses. Missing data were minimal (<5%) and were handled using complete-case analysis.
Univariate analyses were initially performed to identify variables associated with infection. Variables with a p-value < 0.05, as well as those considered clinically relevant, were entered into a multivariable logistic regression model to identify factors independently associated with infectious complications. Clinically relevant variables were evaluated as potential confounders during model construction, and multicollinearity was assessed prior to model development. To minimize the risk of overfitting, the number of predictors included in the model was restricted according to the number of outcome events. Given the number of infection events observed, the number of predictors included in the final model was intentionally limited to preserve model stability and reduce the risk of overfitting.
Model fit was assessed using the Hosmer-Lemeshow goodness-of-fit test. Adjusted odds ratios (OR) with 95% confidence intervals (CI) were reported. All tests were two-tailed, and a p-value < 0.05 was considered statistically significant. Statistical assumptions were verified prior to analysis. All analyses were performed using IBM SPSS Statistics version 25.0 (IBM Corp., Armonk, NY).
Ethical considerations
This study was approved by the institutional ethics committee and conducted in accordance with the Declaration of Helsinki and Mexican regulations. All medical records were fully de-identified prior to data extraction, ensuring that no personal identifiers were included.
Results
A total of 273 burn patients were included. Of these, 196 (71.27%) were men and 79 (28.73%) women, with a mean age of 43.6 ± 18.8 years. The median hospital stay was 14.5 days.
The trunk was the most affected region (52.36%), followed by upper extremities (32.73%), head and neck (13.82%), and lower extremities (10.91%). Most burns were second-degree (68.73%), followed by third-degree (28%) and first-degree (2.55%). Burns >20% TBSA were seen in 21.82% of patients (Table 1). Patient care frequency by hospital is shown in Table 2.
The overall infection rate was 16.1% (44/273). The most frequent pathogen was Pseudomonas aeruginosa (7.64%), followed by Staphylococcus haemolyticus, Staphylococcus epidermidis, Enterococcus faecalis, and Staphylococcus hominis (Table 3). High resistance rates were observed for tobramycin (84.21%), ciprofloxacin (59.46%), vancomycin (35.14%), clindamycin (81.58%), and imipenem (78.4%) (Table 4).
Univariate analysis identified several variables associated with infectious complications (Table 5). Subsequently, multivariable logistic regression was performed to adjust for potential confounders, including clinically relevant variables. Burns involving >20% total body surface area (TBSA), intensive care unit admission, lower extremity burns, and advanced age remained independently associated with infection after adjustment.
Discussion
This study provides a comprehensive analysis of infectious complications among burn patients in a multicenter Mexican cohort over a 10-year period. Our findings reaffirm that infection remains a major cause of morbidity in burn units, with a prevalence of 13.45%, aligning with rates reported in similar resource-limited settings [2,4].
The identification of burns involving >20% total body surface area (TBSA), intensive care unit (ICU) admission, lower extremity involvement, and advanced age as independent risk factors for infection is consistent with previous studies [5-7]. Brusselaers et al. demonstrated that extensive burns (>20%-40% TBSA) were associated with up to a 10-fold increase in infection risk, reflecting the profound immunosuppression and tissue damage present in such patients [1]. Similarly, our results emphasize the relevance of burn size as a reliable predictor of infectious morbidity.
We also observed a significant association between lower extremity burns and infection, which has been previously noted in smaller series [9]. This may be attributed to the anatomical challenges of maintaining asepsis in the lower limbs, greater exposure to environmental contaminants, and impaired perfusion that hinders wound healing. Future studies could further explore the role of regional blood flow and tissue oxygenation in infection risk stratification.
ICU admission and invasive support measures such as mechanical ventilation and central venous catheters are well-recognized contributors to nosocomial infections in critically ill burn patients [3,8]. Our data support this observation, underlining the need for stringent infection control policies in intensive care environments, particularly in patients with high TBSA burns and prolonged stays.
Advanced age was significantly associated with infectious complications, consistent with findings by Alp et al. [8] and others. Aging has been linked to diminished immune competence, delayed wound healing, and increased comorbid burden, which may contribute to a higher susceptibility to infection. Given the observational design of this study, these findings should be interpreted as associations rather than causal relationships. These results may help inform risk stratification and support closer monitoring of elderly burn patients.
Of particular concern was the predominance of Pseudomonas aeruginosa, accounting for more than half of the isolated pathogens, with alarmingly high resistance rates to commonly used antibiotics such as tobramycin (84.21%), imipenem (78.4%), and ciprofloxacin (59.46%). These findings echo global concerns over multidrug-resistant Pseudomonas in burn care, as highlighted by the World Health Organization (WHO) priority pathogen list [10]. The high resistance rates observed in our cohort may reflect both the selective pressure of empirical broad-spectrum antibiotic use and inadequate infection control practices. Implementation of antimicrobial stewardship programs and periodic local antibiograms are critical to guide rational therapy, prevent further resistance, and improve patient outcomes [11].
Beyond individual patient management, our findings carry institutional and public health implications. The identification of specific risk factors enables the development of targeted surveillance and prophylactic interventions, for example, enhanced barrier nursing care and early wound excision in patients with large TBSA burns, or tailored antimicrobial regimens in units with high multidrug-resistant organism (MDRO) prevalence.
This study is subject to several limitations inherent to its retrospective design, including potential underreporting of infections and the inability to establish causality. Furthermore, variations in microbiological surveillance practices among participating centers may have influenced pathogen detection rates. Additionally, this study was conducted within the Petróleos Mexicanos (PEMEX) hospital network, which follows specific care protocols and serves a defined patient population; therefore, the findings may not be fully generalizable to other healthcare settings and should be interpreted in the context of similar tertiary burn centers. Future prospective multicenter studies with standardized definitions and longitudinal follow-up are warranted to validate our findings and quantify the impact of preventive measures. Additionally, excluding patients with incomplete records or limited follow-up may have introduced selection bias. Furthermore, residual confounding from unmeasured variables such as nutritional status, timing of surgical interventions, or duration of invasive device use cannot be entirely ruled out.
Our results underscore the ongoing need for improved infection control protocols, timely wound management, and updated antimicrobial guidelines informed by local resistance patterns. Further research should explore the efficacy of novel therapies, such as topical antimicrobials and adjunctive immunomodulators, particularly in elderly and high-TBSA burn patients. Although multivariable analysis was performed, these findings should be interpreted as associations rather than definitive causal relationships.
Conclusions
Extensive burns (>20% total body surface area), intensive care unit admission, lower extremity involvement, and advanced age were significantly associated with infectious complications in hospitalized burn patients. The high prevalence of multidrug-resistant Pseudomonas aeruginosa underscores the need for ongoing microbiological surveillance and antimicrobial stewardship. Given the observational nature of this study, these findings should be interpreted as associations rather than causal relationships and may help inform risk stratification and preventive strategies in similar burn care settings.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality Crit Care Brusselaers N Monstrey S Vogelaers D Hoste E Blot S 014201010.1186/cc 9300 PMC 321929520958968 · doi ↗ · pubmed ↗
- 2Infections in burn patients Surg Clin North Am Kiley JL Greenhalgh DG 42743710320233714937910.1016/j.suc.2023.02.005 · doi ↗ · pubmed ↗
- 3Burn wound infections Clin Microbiol Rev Church D Elsayed S Reid O Winston B Lindsay R 4034341920061661425510.1128/CMR.19.2.403-434.2006 PMC 1471990 · doi ↗ · pubmed ↗
- 4Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study Antimicrob Resist Infect Control Hu Y Li D Xu L Hu Y Sang Y Zhang G Dai H 981020213419330010.1186/s 13756-021-00969-w PMC 8243830 · doi ↗ · pubmed ↗
- 5Early detection of soluble CD 27, BTLA, and TIM-3 predicts the development of nosocomial infection in pediatric burn patients Front Immunol Penatzer JA Alexander R Simon S 9408351320223595857910.3389/fimmu.2022.940835 PMC 9360547 · doi ↗ · pubmed ↗
- 6Monocytes and T cells incorporated in full skin equivalents to study innate or adaptive immune reactions after burn injury Front Immunol Mulder PP Vlig M Elgersma A 12647161420233790121810.3389/fimmu.2023.1264716 PMC 10611519 · doi ↗ · pubmed ↗
- 7Airway management in inhalation injury: a case series Singapore Med J Desai SR Zeng D Chong SJ 46536120203119737210.11622/smedj.2019048 PMC 7900805 · doi ↗ · pubmed ↗
- 8Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital J Burn Care Res Alp E Coruh A Gunay GK Yontar Y Doganay M 3793853320122207991110.1097/BCR.0b 013e 318234966 c · doi ↗ · pubmed ↗
